Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

NCT02514824 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

NCT03370861 ·Status: TERMINATED

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

NCT05106023 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients

NCT06615635 ·Status: NOT_YET_RECRUITING ·Phase: NA

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

NCT03581188 ·Status: COMPLETED ·Phase: NA

Intratumoral Injection Of Alpha-Gal Glycosphingolipids

NCT00668512 ·Status: COMPLETED ·Phase: PHASE1

Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma

NCT01264731 ·Status: COMPLETED ·Phase: PHASE1

Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma

NCT06894407 ·Status: NOT_YET_RECRUITING ·Phase: NA

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

NCT02094872 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

NCT04869137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.

NCT06608238 ·Status: COMPLETED ·Phase: PHASE2

MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)

NCT03932253 ·Status: SUSPENDED ·Phase: PHASE1

A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

NCT05751928 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma

NCT03028948 ·Status: COMPLETED ·Phase: NA

Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.

NCT03602547 ·Status: UNKNOWN ·Phase: PHASE2

AMT-253 in Patients With Advanced Solid Tumours

NCT06209580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

NCT05135715 ·Status: RECRUITING ·Phase: PHASE2

Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

NCT00559026 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

NCT04653038 ·Status: TERMINATED ·Phase: PHASE1

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

NCT05051865 ·Status: UNKNOWN ·Phase: PHASE2

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

NCT01720407 ·Status: COMPLETED ·Phase: PHASE3

GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma

NCT01245062 ·Status: COMPLETED ·Phase: PHASE3

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions

NCT05907551 ·Status: UNKNOWN

Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery

NCT05594290 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

NCT07280832 ·Status: RECRUITING ·Phase: PHASE1/PHASE2